Identifying groups at high risk for carriage of antibiotic-resistant bacteria.
暂无分享,去创建一个
Joseph Finkelstein | Jessina C. McGregor | Patricia Langenberg | R. Venezia | A. Harris | E. Perencevich | P. Langenberg | J. Finkelstein | Judith A. Johnson | J. Furuno | S. M. Strauss | Jon P Furuno | Sandra M Strauss | Anthony D Harris | Eli N Perencevich | Jessina C McGregor | Judith A Johnson | Sandra M. Strauss | Richard A Venezia | Jennifer K Johnson | David L Smith | J. McGregor | David L Smith | Jennifer K Johnson | David L. Smith
[1] D. Calfee,et al. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. , 2004, American journal of infection control.
[3] J. Bartlett. Methicillin-resistant Staphylococcus aureus infections in correctional facilities---Georgia, California, and Texas, 2001-2003. , 2003, MMWR. Morbidity and mortality weekly report.
[4] Y. Carmeli,et al. Carriage of Methicillin-Resistant Staphylococcus Aureus at Hospital Admission , 1998, Infection Control & Hospital Epidemiology.
[5] J. Jernigan,et al. Prevalence of and Risk Factors for Colonization With Methicillin-Resistant Staphylococcus aureus in an Outpatient Clinic Population , 2003, Infection Control & Hospital Epidemiology.
[6] T. Karchmer,et al. Cost-effectiveness of active surveillance cultures and contact/droplet precautions for control of methicillin-resistant Staphylococcus aureus. , 2002, The Journal of hospital infection.
[7] M. Collins,et al. Identification of Enterococcus species isolated from human infections by a conventional test scheme , 1989, Journal of clinical microbiology.
[8] S. Ghosh,et al. Prevalence of methicillin-resistant Staphylococcus aureus colonization in surgical patients, on admission to a Welsh hospital. , 2002, The Journal of hospital infection.
[9] A. Harris,et al. Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] D. Hospenthal,et al. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] C. Brun-Buisson,et al. Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. , 1999, JAMA.
[12] A. Harris,et al. Risk Factors for Piperacillin-Tazobactam-Resistant Pseudomonas aeruginosa among Hospitalized Patients , 2002, Antimicrobial Agents and Chemotherapy.
[13] Carlene A. Muto,et al. SHEA Guideline for Preventing Nosocomial Transmission of Multidrug-Resistant Strains of Staphylococcus aureus and Enterococcus , 2003, Infection Control & Hospital Epidemiology.
[14] J. Morris,et al. Epidemiological Risk Factors for Isolation of Ceftriaxone-Resistant versus -Susceptible Citrobacter freundii in Hospitalized Patients , 2003, Antimicrobial Agents and Chemotherapy.
[15] R. Venezia,et al. Prediction rules to identify patients with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci upon hospital admission. , 2004, American journal of infection control.
[16] Nnis System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003. , 2003, American journal of infection control.
[17] Methicillin-resistant Staphylococcus aureus skin or soft tissue infections in a state prison--Mississippi, 2000. , 2001, MMWR. Morbidity and mortality weekly report.
[18] Injury rates by industry 1970, BLS Report 406, Department of Labor, Bureau of Labor Statistics. , 1972, IMS, Industrial medicine and surgery.
[19] M. Edmond. Cost-Effectiveness of Perirectal Surveillance Cultures for Controlling Vancomycin-Resistant Enterococcus , 2003, Infection Control & Hospital Epidemiology.
[20] Jessina C. McGregor,et al. Utility of the Chronic Disease Score and Charlson Comorbidity Index as comorbidity measures for use in epidemiologic studies of antibiotic-resistant organisms. , 2005, American journal of epidemiology.